# Tryptophan MRI in People With Schizophrenia and Healthy Controls

> **NCT02067975** · PHASE2,PHASE3 · COMPLETED · sponsor: **University of Maryland, Baltimore** · enrollment: 93 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** Tryptophan
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02067975
- **Lead sponsor:** University of Maryland, Baltimore
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-08-14
- **Primary completion:** 2019-12-31
- **Final completion:** 2019-12-31
- **Target enrollment:** 93 (ACTUAL)
- **Last updated:** 2024-07-30

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02067975

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02067975, "Tryptophan MRI in People With Schizophrenia and Healthy Controls". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02067975. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*